# Envoy Medical, Inc.: filings

COCH · Nasdaq · CIK 1840877 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/coch.md) · [Financials](/companies/coch/financials.md) · [Filings](/companies/coch/filings.md) · [Insiders](/companies/coch/insiders.md)

## Reports and events: 129 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 81, 4 56, 3 19, 10-Q 17, 424B3 17, CORRESP 14, DEFA14A 12, UPLOAD 11, EFFECT 8, DEF 14A 7, S-1/A 7, 10-K 5, 425 5, PRE 14A 5, S-4/A 5, 424B5 4, S-1 4, SC 13G 4, SCHEDULE 13G 4, SCHEDULE 13G/A 4, 424B4 3, ARS 3, POS AM 3, SC 13G/A 3, 10-Q/A 2, 8-K/A 2, DRS 2, NT 10-Q 2, S-1MEF 2, S-8 2, SCHEDULE 13D 2, 10-K/A 1, 25-NSE 1, 4/A 1, 8-A12B 1, CERT 1, DRSLTR 1, NT 10-K 1, S-3 1, S-4 1, SCHEDULE 13D/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-16 | 16:30 ET | [8-K](/filings/0001213900-26-110266.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-26-110266 |
| 2026-10-07 | 09:00 ET | [8-K](/filings/0001213900-26-107434.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-107434 |
| 2026-08-31 | 16:30 ET | [DEF 14A](/filings/0001213900-26-095756.md) | Proxy statement, period 2026-10-12 | 0001213900-26-095756 |
| 2026-08-27 | 17:29 ET | [8-K](/filings/0001213900-26-094447.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-26-094447 |
| 2026-08-10 | 16:01 ET | [8-K](/filings/0001213900-26-087221.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-087221 |
| 2026-08-10 | 08:31 ET | [10-Q](/filings/0001213900-26-086974.md) | Quarterly report, period 2026-06-30 | 0001213900-26-086974 |
| 2026-06-30 | 16:00 ET | [8-K](/filings/0001213900-26-073659.md) | 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001213900-26-073659 |
| 2026-06-25 | 16:01 ET | [8-K](/filings/0001213900-26-072033.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-26-072033 |
| 2026-05-22 | 16:05 ET | [8-K](/filings/0001213900-26-060556.md) | 3.01 Delisting notice | 0001213900-26-060556 |
| 2026-05-18 | 16:05 ET | [8-K](/filings/0001213900-26-058429.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-26-058429 |
| 2026-05-11 | 08:30 ET | [10-Q](/filings/0001213900-26-054209.md) | Quarterly report, period 2026-03-31 | 0001213900-26-054209 |
| 2026-05-11 | 08:00 ET | [8-K](/filings/0001213900-26-054185.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-054185 |
| 2026-04-21 | 16:25 ET | [8-K](/filings/0001213900-26-046197.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-26-046197 |
| 2026-04-13 | 16:30 ET | [10-K/A](/filings/0001213900-26-043011.md) | Annual report, amended, period 2025-12-31 | 0001213900-26-043011 |
| 2026-04-02 | 16:01 ET | [DEF 14A](/filings/0001213900-26-039310.md) | Proxy statement, period 2026-05-12 | 0001213900-26-039310 |
| 2026-03-31 | 16:05 ET | [8-K](/filings/0001213900-26-037419.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001213900-26-037419 |
| 2026-03-27 | 16:01 ET | [8-K](/filings/0001213900-26-035483.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-035483 |
| 2026-03-23 | 09:26 ET | [10-K](/filings/0001213900-26-032683.md) | Annual report, period 2025-12-31 | 0001213900-26-032683 |
| 2026-02-27 | 09:11 ET | [8-K](/filings/0001213900-26-021116.md) | 3.01 Delisting notice; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-021116 |
| 2026-02-17 | 09:14 ET | [SCHEDULE 13D/A](/filings/0001104659-26-015955.md) | Ownership report, active investor, amended | 0001104659-26-015955 |
| 2026-02-13 | 17:17 ET | [8-K](/filings/0001213900-26-016584.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-016584 |
| 2026-02-11 | 16:00 ET | [8-K](/filings/0001213900-26-014878.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-26-014878 |
| 2026-02-10 | 21:55 ET | [S-1/A](/filings/0001213900-26-013894.md) | Registration statement, amended | 0001213900-26-013894 |
| 2026-02-06 | 10:58 ET | [S-1/A](/filings/0001213900-26-013098.md) | Registration statement, amended | 0001213900-26-013098 |
| 2025-12-29 | 16:01 ET | [8-K](/filings/0001213900-25-126032.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-25-126032 |
| 2025-12-18 | 17:20 ET | [S-1](/filings/0001213900-25-123367.md) | Registration statement | 0001213900-25-123367 |
| 2025-12-16 | 09:47 ET | [8-K](/filings/0001213900-25-121987.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-121987 |
| 2025-12-08 | 06:09 ET | [SCHEDULE 13D](/filings/0001104659-25-119019.md) | Ownership report, active investor | 0001104659-25-119019 |
| 2025-12-03 | 16:01 ET | [8-K](/filings/0001213900-25-117805.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-25-117805 |
| 2025-12-01 | 16:31 ET | [S-1/A](/filings/0001213900-25-116721.md) | Registration statement, amended | 0001213900-25-116721 |
| 2025-11-25 | 16:01 ET | [8-K](/filings/0001213900-25-114725.md) | 3.01 Delisting notice | 0001213900-25-114725 |
| 2025-11-10 | 08:31 ET | [10-Q](/filings/0001213900-25-107902.md) | Quarterly report, period 2025-09-30 | 0001213900-25-107902 |
| 2025-11-10 | 08:30 ET | [8-K](/filings/0001213900-25-107898.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-107898 |
| 2025-10-28 | 09:22 ET | [8-K](/filings/0001213900-25-102828.md) | 3.01 Delisting notice; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-102828 |
| 2025-10-17 | 16:05 ET | [DEF 14A](/filings/0001213900-25-099960.md) | Proxy statement, period 2025-11-26 | 0001213900-25-099960 |
| 2025-10-17 | 10:59 ET | [S-1](/filings/0001213900-25-099775.md) | Registration statement | 0001213900-25-099775 |
| 2025-10-09 | 09:15 ET | [8-K](/filings/0001213900-25-097600.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-097600 |
| 2025-10-07 | 10:04 ET | [8-K](/filings/0001213900-25-096845.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-096845 |
| 2025-09-23 | 09:56 ET | [8-K](/filings/0001213900-25-090373.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-090373 |
| 2025-09-19 | 06:23 ET | [8-K](/filings/0001213900-25-089225.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-089225 |
| 2025-09-09 | 17:25 ET | [8-K](/filings/0001213900-25-086268.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-25-086268 |
| 2025-08-29 | 16:30 ET | [8-K](/filings/0001213900-25-082608.md) | 3.01 Delisting notice | 0001213900-25-082608 |
| 2025-08-26 | 08:35 ET | [8-K](/filings/0001213900-25-080530.md) | 1.02 Termination of a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-25-080530 |
| 2025-07-31 | 08:30 ET | [10-Q](/filings/0001213900-25-069663.md) | Quarterly report, period 2025-06-30 | 0001213900-25-069663 |
| 2025-07-31 | 08:25 ET | [8-K](/filings/0001213900-25-069658.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-069658 |
| 2025-07-29 | 16:54 ET | [8-K](/filings/0001213900-25-068760.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-25-068760 |
| 2025-07-02 | 16:31 ET | [8-K](/filings/0001213900-25-061057.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-25-061057 |
| 2025-06-25 | 08:30 ET | [8-K](/filings/0001213900-25-057481.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-25-057481 |
| 2025-06-03 | 16:00 ET | [8-K](/filings/0001213900-25-050758.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-25-050758 |
| 2025-05-19 | 08:52 ET | [8-K](/filings/0001213900-25-045109.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-25-045109 |

Page 1 of 3. [Older](/companies/coch/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 08:41 ET. No prices; not investment advice.